Viatris Inc. Common Stock VTRS
HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERICi
Market dataready · fetched 2026-11-12T03:23:56.493Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-12T00:19:26.677843977Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-12T03:14:00.055043+00:00
Viatris Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 21.95 | 31.0% | 5.0% | 20.11 | 33.5% | 4.9% |
| 25Δ | 21.80 | 31.0% | 4.6% | 20.27 | 33.1% | 4.4% |
| 30Δ | 21.65 | 31.1% | 4.1% | 20.43 | 32.8% | 3.8% |
| 35Δ | 21.51 | 31.1% | 3.6% | 20.59 | 32.4% | 3.3% |
| 40Δ | 21.36 | 31.1% | 3.1% | 20.75 | 32.1% | 2.8% |
| 45Δ | 21.21 | 31.2% | 2.7% | 20.91 | 31.7% | 2.3% |
| 50Δ | 21.06 | 31.2% | 2.2% | 21.09 | 33.3% | 1.9% |
| 55Δ | 20.89 | 32.7% | 1.9% | 21.32 | 37.7% | 1.8% |
| 60Δ | 20.69 | 35.3% | 1.7% | 21.55 | 42.0% | 1.6% |
| 65Δ | 20.49 | 37.9% | 1.5% | 21.77 | 46.4% | 1.5% |
| 70Δ | 20.29 | 40.5% | 1.3% | 22.00 | 50.7% | 1.4% |
| 75Δ | 20.10 | 43.1% | 1.1% | 22.67 | 56.1% | 1.1% |
| 80Δ | 19.84 | 44.5% | 0.9% | 23.35 | 61.5% | 0.9% |
20Δ
- Pseudo strike
- 21.95
- IV
- 31.0%
- B/E move
- 5.0%
- Pseudo strike
- 20.11
- IV
- 33.5%
- B/E move
- 4.9%
25Δ
- Pseudo strike
- 21.80
- IV
- 31.0%
- B/E move
- 4.6%
- Pseudo strike
- 20.27
- IV
- 33.1%
- B/E move
- 4.4%
30Δ
- Pseudo strike
- 21.65
- IV
- 31.1%
- B/E move
- 4.1%
- Pseudo strike
- 20.43
- IV
- 32.8%
- B/E move
- 3.8%
35Δ
- Pseudo strike
- 21.51
- IV
- 31.1%
- B/E move
- 3.6%
- Pseudo strike
- 20.59
- IV
- 32.4%
- B/E move
- 3.3%
40Δ
- Pseudo strike
- 21.36
- IV
- 31.1%
- B/E move
- 3.1%
- Pseudo strike
- 20.75
- IV
- 32.1%
- B/E move
- 2.8%
45Δ
- Pseudo strike
- 21.21
- IV
- 31.2%
- B/E move
- 2.7%
- Pseudo strike
- 20.91
- IV
- 31.7%
- B/E move
- 2.3%
50Δ
- Pseudo strike
- 21.06
- IV
- 31.2%
- B/E move
- 2.2%
- Pseudo strike
- 21.09
- IV
- 33.3%
- B/E move
- 1.9%
55Δ
- Pseudo strike
- 20.89
- IV
- 32.7%
- B/E move
- 1.9%
- Pseudo strike
- 21.32
- IV
- 37.7%
- B/E move
- 1.8%
60Δ
- Pseudo strike
- 20.69
- IV
- 35.3%
- B/E move
- 1.7%
- Pseudo strike
- 21.55
- IV
- 42.0%
- B/E move
- 1.6%
65Δ
- Pseudo strike
- 20.49
- IV
- 37.9%
- B/E move
- 1.5%
- Pseudo strike
- 21.77
- IV
- 46.4%
- B/E move
- 1.5%
70Δ
- Pseudo strike
- 20.29
- IV
- 40.5%
- B/E move
- 1.3%
- Pseudo strike
- 22.00
- IV
- 50.7%
- B/E move
- 1.4%
75Δ
- Pseudo strike
- 20.10
- IV
- 43.1%
- B/E move
- 1.1%
- Pseudo strike
- 22.67
- IV
- 56.1%
- B/E move
- 1.1%
80Δ
- Pseudo strike
- 19.84
- IV
- 44.5%
- B/E move
- 0.9%
- Pseudo strike
- 23.35
- IV
- 61.5%
- B/E move
- 0.9%
Options history
Table
| Date | IV (%) |
|---|---|
| 34.25% | |
| 34.38% | |
| 33.71% | |
| 34.49% | |
| 36.95% | |
| 37.78% | |
| 35.19% | |
| 35.83% | |
| 36.67% | |
| 36.11% |
Drug Manufacturers - Specialty & Generic
XERS
Description unavailable
More →ZTS
Description unavailable
More →ACB
Aurora Cannabis Inc. produces and distributes medical cannabis products globally. The company is headquartered in Edmonton, Canada.
More →AKBA
Description unavailable
More →ALKS
Alkermes plc, a biopharmaceutical company, researches, develops and markets pharmaceutical products to address the unmet medical needs of patients in various therapeutic areas in…
More →AMLX
Amylyx Pharmaceuticals Inc (AMLX) is an innovative biopharmaceutical company at the forefront of developing transformative therapies for neurodegenerative diseases, particularly…
More →